← Human Trials & Peer-Reviewed Studies
Impact and Duration of Brief Surgeon-Delivered Smoking Cessation Advice on Attitudes Regarding Nicotine Dependence and Tobacco Harms for Patients with Peripheral Arterial Disease.
Plain-language guide to PMID 27521828 (2017): pilot randomized controlled trial of Therapeutic nicotine (patch, non-peptide).
Key Facts
- PMID
- 27521828
- Journal
- Annals of vascular surgery
- Year
- 2017
- Study type
- Randomized Controlled Trial
- Authors
- Newhall K et al. (10 authors)
- DOI
- 10.1016/j.avsg.2016.06.005
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.
The researchers investigated the impact and durability of a multimodal smoking cessation intervention on patient attitudes regarding nicotine dependence and the health effects of smoking.
Who Took Part
The age groups tagged for this paper are middle-aged adults and older adults, both men and women.
Compared with control sites, patients at intervention sites received protocolized brief cessation counseling, medications, and referrals to a quitline.
After their clinic visit and again at 3 months, participants completed a brief survey about patient attitudes regarding nicotine dependence and the health effects of smoking.
How the Study Was Run
The design is described as randomized and pilot.
The participants were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.
It is described as a pilot, a small early test of whether a larger Therapeutic nicotine (patch, non-peptide) study would be practical.
The researchers conducted a pilot cluster-randomized trial of a brief smoking cessation intervention at 8 vascular surgery practices between September 1, 2014 and August 31, 2015.
Responses to questions were analyzed using chi-squared test and Student's t-test.
What Was Measured
Topics PubMed links to this paper include Awareness, Chi-Square Distribution, Counseling, Health Knowledge, Attitudes, Practice, Motivation, Patient Compliance and Patient Education as Topic.
What This Means in Plain Language
The paper is a randomized and pilot study of Therapeutic nicotine (patch, non-peptide).
Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2017 (Annals of vascular surgery), a journal based in Netherlands.
More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.
Our Notes on the Compound
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.